Actualités Hutchmed (china) Limited - HCM | Actions London Stock Exchange

Hutchmed (China) Limited Directorate Change

Hutchmed (China) Limited 05 March 2025 HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee ...

Hutchmed (China) Limited Overseas Regulatory Announcement

Hutchmed (China) Limited 03 March 2025 Overseas Regulatory Announcement - Update on Transaction HUTCHMED (China) Limited ("HUTCHMED...

Hutchmed (China) Limited Overseas Regulatory Announcement

Hutchmed (China) Limited 28 February 2025 Overseas Regulatory Announcement - Update on Transaction HUTCHMED (China) Limited ("HUTCHMED...

Hutchmed (China) Limited Notice of Results

Hutchmed (China) Limited 19 February 2025 HUTCHMED to Announce 2024 Final Results Hong Kong, Shanghai & Florham Park, NJ - Wednesday...

Hutchmed (China) Limited Overseas Regulatory Announcement

Hutchmed (China) Limited 28 January 2025 Overseas Regulatory Announcement - Disposal Transaction HUTCHMED (China) Limited ("HUTCHMED...

IN BRIEF: Hutchmed lung cancer treatment Orpathys approved in China

Ltd - Hong Kong-based biopharmaceutical firm - Says its lung cancer treatment Orpathys has received full approval in C ...

Hutchmed China disposes of 45% stake in Shanghai joint venture

Hutchmed (China) Ltd on Thursday said it has agreed to divest a 45% stake in Shanghai Hutchison Pharmaceuticals Ltd t ...

Hutchmed (China) Limited Overseas Regulatory Announcement

Hutchmed (China) Limited 02 January 2025 Overseas Regulatory Announcement - Disposal Transaction HUTCHMED (China) Limited ("HUTCHMED...

Hutchmed (China) Limited US$608m Divestment of Non-Core Joint Venture

Hutchmed (China) Limited 02 January 2025 HUTCHMED Announces US$608 million Divestment of Non-Core Joint Venture - HUTCHMED continues to...

Hutchmed (China) Limited Appointment of Joint Corporate Broker

Hutchmed (China) Limited 31 December 2024 Appointment of Cavendish as Joint Corporate Broker in London Hong Kong, Shanghai & Florham...

Hutchmed (China) Limited Blocklisting Six Monthly Return

Hutchmed (China) Limited 30 December 2024 Blocklisting Six Monthly Return Hong Kong, Shanghai & Florham Park, NJ - Monday, December 30...

IN BRIEF: Hutchmed to get Takeda milestone payment

Ltd - Hong Kong-based biopharmaceutical firm - Is to receive a USD10 million milestone payment from partner Takeda Pha ...

Hutchmed China injection approval could be a "paradigm shift"

Hutchmed China Ltd on Tuesday reported it was granted conditional approval in China for an injection to treat endomet ...

Hutchmed (China) Limited Total Voting Rights

Hutchmed (China) Limited 29 November 2024 Total Voting Rights Hong Kong, Shanghai & Florham Park, NJ - Friday, November 29, 2024:...

Hutchmed to get payment from Takeda as Fruzaqla launched in Japan

Hutchmed (China) Ltd on Friday said it will receive a milestone payment from Takeda Pharmaceutical Co Ltd after Taked ...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Hutchmed (china) Limited (HCM)

Votre Hub pour des idées et discussions en direct en temps réel

HCM Actualités

Hutchmed (China) Limited Directorate Change

Hutchmed (China) Limited Overseas Regulatory Announcement

Hutchmed (China) Limited Overseas Regulatory Announcement

Hutchmed (China) Limited Notice of Results

Hutchmed (China) Limited Overseas Regulatory Announcement

IN BRIEF: Hutchmed lung cancer treatment Orpathys approved in China

Hutchmed China disposes of 45% stake in Shanghai joint venture

Hutchmed (China) Limited Overseas Regulatory Announcement

Hutchmed (China) Limited US$608m Divestment of Non-Core Joint Venture

Hutchmed (China) Limited Appointment of Joint Corporate Broker

Hutchmed (China) Limited Blocklisting Six Monthly Return

IN BRIEF: Hutchmed to get Takeda milestone payment

Hutchmed China injection approval could be a "paradigm shift"

Hutchmed (China) Limited Total Voting Rights

Hutchmed to get payment from Takeda as Fruzaqla launched in Japan

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Hutchmed (china) Limited (HCM) Actualités

Hutchmed (china) Limited (HCM)

Votre Hub pour des idées et discussions en direct en temps réel

HCM Actualités

Hutchmed (China) Limited Directorate Change

Hutchmed (China) Limited Overseas Regulatory Announcement

Hutchmed (China) Limited Overseas Regulatory Announcement

Hutchmed (China) Limited Notice of Results

Hutchmed (China) Limited Overseas Regulatory Announcement

IN BRIEF: Hutchmed lung cancer treatment Orpathys approved in China

Hutchmed China disposes of 45% stake in Shanghai joint venture

Hutchmed (China) Limited Overseas Regulatory Announcement

Hutchmed (China) Limited US$608m Divestment of Non-Core Joint Venture

Hutchmed (China) Limited Appointment of Joint Corporate Broker

Hutchmed (China) Limited Blocklisting Six Monthly Return

IN BRIEF: Hutchmed to get Takeda milestone payment

Hutchmed China injection approval could be a "paradigm shift"

Hutchmed (China) Limited Total Voting Rights

Hutchmed to get payment from Takeda as Fruzaqla launched in Japan

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités